» Articles » PMID: 37838760

The Maximal and Current Accuracy of Rigorous Protein-ligand Binding Free Energy Calculations

Overview
Journal Commun Chem
Publisher Springer Nature
Specialty Chemistry
Date 2023 Oct 14
PMID 37838760
Authors
Affiliations
Soon will be listed here.
Abstract

Computational techniques can speed up the identification of hits and accelerate the development of candidate molecules for drug discovery. Among techniques for predicting relative binding affinities, the most consistently accurate is free energy perturbation (FEP), a class of rigorous physics-based methods. However, uncertainty remains about how accurate FEP is and can ever be. Here, we present what we believe to be the largest publicly available dataset of proteins and congeneric series of small molecules, and assess the accuracy of the leading FEP workflow. To ascertain the limit of achievable accuracy, we also survey the reproducibility of experimental relative affinity measurements. We find a wide variability in experimental accuracy and a correspondence between binding and functional assays. When careful preparation of protein and ligand structures is undertaken, FEP can achieve accuracy comparable to experimental reproducibility. Throughout, we highlight reliable protocols that can help maximize the accuracy of FEP in prospective studies.

Citing Articles

Prospective evaluation of structure-based simulations reveal their ability to predict the impact of kinase mutations on inhibitor binding.

Singh S, Gapsys V, Aldeghi M, Schaller D, Rangwala A, White J bioRxiv. 2025; .

PMID: 40060600 PMC: 11888192. DOI: 10.1101/2024.11.15.623861.


Narrowing the gap between machine learning scoring functions and free energy perturbation using augmented data.

Valsson I, Warren M, Deane C, Magarkar A, Morris G, Biggin P Commun Chem. 2025; 8(1):41.

PMID: 39922899 PMC: 11807228. DOI: 10.1038/s42004-025-01428-y.


How does machine learning augment alchemical binding free energy calculations?.

Muegge I, Ge Y Future Med Chem. 2025; 17(5):509-511.

PMID: 39922803 PMC: 11901427. DOI: 10.1080/17568919.2025.2463870.


Macromolecular crystallography from an industrial perspective - the impact of synchrotron radiation on structure-based drug discovery.

Kack H, Sjogren T J Synchrotron Radiat. 2025; 32(Pt 2):294-303.

PMID: 39913304 PMC: 11892899. DOI: 10.1107/S1600577524012281.


The physics-AI dialogue in drug design.

Vargas-Rosales P, Caflisch A RSC Med Chem. 2025; .

PMID: 39906313 PMC: 11788922. DOI: 10.1039/d4md00869c.


References
1.
Jama M, Ahmed M, Jutla A, Wiethan C, Kumar J, Moon T . Discovery of allosteric SHP2 inhibitors through ensemble-based consensus molecular docking, endpoint and absolute binding free energy calculations. Comput Biol Med. 2022; 152:106442. DOI: 10.1016/j.compbiomed.2022.106442. View

2.
Wang L, Friesner R, Berne B . Replica exchange with solute scaling: a more efficient version of replica exchange with solute tempering (REST2). J Phys Chem B. 2011; 115(30):9431-8. PMC: 3172817. DOI: 10.1021/jp204407d. View

3.
Brown S, Muchmore S, Hajduk P . Healthy skepticism: assessing realistic model performance. Drug Discov Today. 2009; 14(7-8):420-7. DOI: 10.1016/j.drudis.2009.01.012. View

4.
Abel R, Wang L, Harder E, Berne B, Friesner R . Advancing Drug Discovery through Enhanced Free Energy Calculations. Acc Chem Res. 2017; 50(7):1625-1632. DOI: 10.1021/acs.accounts.7b00083. View

5.
Lin Z, Zou J, Liu S, Peng C, Li Z, Wan X . A Cloud Computing Platform for Scalable Relative and Absolute Binding Free Energy Predictions: New Opportunities and Challenges for Drug Discovery. J Chem Inf Model. 2021; 61(6):2720-2732. DOI: 10.1021/acs.jcim.0c01329. View